Exploring the Protective Effects of Lonicera japonica Flower Buds Against LPS-Induced Acute Lung Injury: Integrated Bioinformatics and In Vivo Pharmacological Investigation

Background: The dried flower buds of Lonicera japonica Thunb. (LJFB) have traditionally been used for febrile- and inflammation-related conditions. Its anti-inflammatory activity provides a rationale for further investigating its protective effects against acute lung injury (ALI), although the underlying chemical and molecular basis remains incompletely understood. Methods: Ultra-Performance Liquid Chromatography–tandem mass spectrometry (UPLC–MS/MS) was employed to profile the chemical constituents of LJFB. Human transcriptomic datasets were analyzed using differential expression analysis and weighted gene co-expression network analysis (WGCNA). These results were integrated with network pharmacology and machine learning to prioritize candidate targets and related signaling pathways. The protective effects of LJFB and associated molecular changes were subsequently assessed in rats with ALI elicited by LPS. Results: A total of 24 constituents were identified, of which 11 were quantified. Integrated network pharmacology and transcriptomic analyses prioritized PI3K–AKT and NF-κB signaling for further investigation, while machine learning prioritized the Pim-1 proto-oncogene, a serine/threonine kinase (PIM1), as a candidate target. In vivo experiments showed that LJFB alleviated pulmonary edema and histopathological injury and improved inflammation- and apoptosis-related abnormalities. LJFB also reduced PIM1 protein expression and decreased the p-PI3K/PI3K, p-AKT/AKT, p-IκBα/IκBα, and p-p65/p65 ratios. Intervention with the PI3K activator 740Y-P partially reversed several protective effects of LJFB and the associated signaling changes. Conclusions: LJFB alleviated ALI triggered by LPS in rats. These findings support the involvement of PI3K–AKT signaling in LJFB-associated protection, accompanied by changes in NF-κB-related signaling. PIM1 was further prioritized as a candidate target for subsequent functional investigation.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-05
DOI
https://doi.org/10.3390/ph19111758
Primary Topic
Traditional Chinese Medicine Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Exploring the Protective Effects of Lonicera japonica Flower Buds Against LPS-Induced Acute Lung Injury: Integrated Bioinformatics and In Vivo Pharmacological Investigation

Liangqi Zhang, Fang He, Qiang Xiao, Meifeng Xiao et al.
Pharmaceuticals
Traditional Chinese Medicine Analysis
article

Exploring the Protective Effects of Lonicera japonica Flower Buds Against LPS-Induced Acute Lung Injury: Integrated Bioinformatics and In Vivo Pharmacological Investigation

Liangqi Zhang, Fang He, Qiang Xiao, Meifeng Xiao, Ru Qiao, Qin Yuan, Can Liu, Wenjiao Li
article en

Abstract

Background: The dried flower buds of Lonicera japonica Thunb. (LJFB) have traditionally been used for febrile- and inflammation-related conditions. Its anti-inflammatory activity provides a rationale for further investigating its protective effects against acute lung injury (ALI), although the underlying chemical and molecular basis remains incompletely understood. Methods: Ultra-Performance Liquid Chromatography–tandem mass spectrometry (UPLC–MS/MS) was employed to profile the chemical constituents of LJFB. Human transcriptomic datasets were analyzed using differential expression analysis and weighted gene co-expression network analysis (WGCNA). These results were integrated with network pharmacology and machine learning to prioritize candidate targets and related signaling pathways. The protective effects of LJFB and associated molecular changes were subsequently assessed in rats with ALI elicited by LPS. Results: A total of 24 constituents were identified, of which 11 were quantified. Integrated network pharmacology and transcriptomic analyses prioritized PI3K–AKT and NF-κB signaling for further investigation, while machine learning prioritized the Pim-1 proto-oncogene, a serine/threonine kinase (PIM1), as a candidate target. In vivo experiments showed that LJFB alleviated pulmonary edema and histopathological injury and improved inflammation- and apoptosis-related abnormalities. LJFB also reduced PIM1 protein expression and decreased the p-PI3K/PI3K, p-AKT/AKT, p-IκBα/IκBα, and p-p65/p65 ratios. Intervention with the PI3K activator 740Y-P partially reversed several protective effects of LJFB and the associated signaling changes. Conclusions: LJFB alleviated ALI triggered by LPS in rats. These findings support the involvement of PI3K–AKT signaling in LJFB-associated protection, accompanied by changes in NF-κB-related signaling. PIM1 was further prioritized as a candidate target for subsequent functional investigation.

PharmaceuticalsVol. 19(11)
Hunan University of Traditional Chinese Medicine (CN)
Openalex Percentile: Top 7%
Traditional Chinese Medicine Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon